Showing posts with label Bacterial Pneumonia. Show all posts
Showing posts with label Bacterial Pneumonia. Show all posts

Wednesday, July 24, 2013

Sweden Reports Rare Outbreak Of Parrot Fever

image

Photo Credit USDA

 

# 7510

 

 

Although relatively rare, an outbreak of Psittacosis (parrot fever) is in the news once again, this time in Sweden where a 75-year old man has died, and 8 others have been infected.  

 

Chlamydophila psittaci bacteria – which is shed in the feces of infected Psittaciformes (cockatoos, parrots, parakeets, lories, etc.) and poultry (ducks & turkeys primarily, less often in chickens) - can cause serious pneumonia in humans.

 

The route of infection is almost always via direct contact with birds or bird feces, but a few instances of human-to-human transmission have been either documented, or strongly suspected.

 

First the report from Sweden – where we learn about an outbreak that occurred last March (no word why we are just now hearing about it) and appears to have involved H-2-H transmission.  I’ll have more on this rare form of bacterial pneumonia when you      return.  

 

Sweden hit by outbreak of rare parrot fever

Published: 24 Jul 2013 09:38 CET

A Swedish man who died of parrot fever in southern Sweden has transmitted the rare disease to at least eight people, with experts pointing out that human-to-human transmission is exceptionally uncommon.

 

After a 75-year-old man died in Kronoberg in March from parrot fever, the illness has spread among those who were near to him during his illness, including care personnel.

 

"This person was very sick and it was an extreme case. It's still hugely uncommon though, no one was infected third hand from the secondary cases we had," Arne Runehagen, doctor at the Swedish Institute for Infectious Disease Control (Smittskyddsinstitutet), told the TT news agency.

(Continue . . .)

 

Sweden reports 5 to 10 cases of Psittacosis each year, but outbreaks of this size are very rare. In 2007, in neighboring Norway, we did see a very large outbreak where `dozens’ were reportedly sickened after attending a bird show (see To You, My Heart Cries Out Chlamydia).

 

Today’s report refers to a previously documented case of human-to-human transmission of Psittacosis in Scotland, which is likely this one from the May of 2012 in the journal Eurosurveillance on an outbreak in Tayside, Scotland, where H-2-H transmission appears to have occurred.

 

Psittacosis outbreak in Tayside, Scotland, December 2011 to February 2012

C C McGuigan , P G McIntyre, K Templeton

A Tayside outbreak of psittacosis December 2011–February 2012 involved three confirmed and one probable cases. Confirmed cases were indistinguishable by sequencing of polymerase chain reaction (PCR) products.

 

The epidemiological pattern suggested person-to-person spread as illness onset dates were consistent with the incubation period and no single common exposure could explain the infections. In particular the only common exposure for a healthcare worker case is overlap in place and time with the symptomatic index case.

 

 

Last November in Psittacosis Identified In Hong Kong Respiratory Outbreak, we saw a limited outbreak among personnel at an agricultural station where smuggled birds seized by customs agents had been quarantined. Subsequently 3 parrots died, and 10 were euthanized.

 

While outbreaks are uncommon, the CDC reports roughly 50 cases are diagnosed each year in the United States. As it can be difficult to diagnose, the true incidence of this disease probably much higher.

 

Treatment is via antibiotics, primarily with tetracycline.

 

One of the concerns with this disease is the widespread and essentially unregulated use of antibiotics by bird owners in treating their flocks.  Overuse of antibiotics can lead to the development of resistant bacteria.

 

In 2007, an EID Journal report Chlamydophila psittaci Transmission from Pet Birds to Humans looked at the use of antibiotics at 39 breeding bird breeding facilities in Belgium, and found that more that 40% had used antibiotics to treat sick birds in the previous 12 months. More than 10% routinely gave antibiotics to birds prophylactically.

 

Although a small study, their findings suggested that bird owners may be infected – and display only mild symptoms - more often than previously suspected. 

 

That said, among a small survey of bird owners - roughly 25% had reported having had pneumonia after acquiring a Psittaciforme as a pet - a number far greater than would normally be seen in the general population.

 

Prior to the development of antibiotics in the middle of last century, the mortality rate from psittacosis pneumonia was on the order of 15% to 20%. Today, if properly diagnosed and treated, deaths are rare.

 

One of the most fascinating stories regarding Parrot Fever came just 10 years after the end of the Spanish Flu Pandemic, when a multi-state outbreak of Parrot Fever briefly stoked pandemic fears once again.

 

I wrote about It’s surprising long term impact in How Parrot Fever Changed Public Health In America.

 

The CDC maintains a Psittacosis website, with the following information.

 

Clinical Features
In humans, fever, chills, headache, muscle aches, and a dry cough. Pneumonia is often evident on chest x-ray.

Etiologic Agent
Chlamydia psittaci, a bacterium

Incidence
Since 1996, fewer than 50 confirmed cases were reported in the United States each year. Many more cases may occur that are not correctly diagnosed or reported.

Sequelae
Endocarditis, hepatitis, and neurologic complications may occasionally occur. Severe pneumonia requiring intensive-care support may also occur. Fatal cases have been reported.

Transmission
Infection is acquired by inhaling dried secretions from infected birds. The incubation period is 5 to 19 days. Although all birds are susceptible, pet birds (parrots, parakeets, macaws, and cockatiels) and poultry (turkeys and ducks) are most frequently involved in transmission to humans.

Risk Groups
Bird owners, pet shop employees, and veterinarians. Outbreaks of psittacosis in poultry processing plants have been reported.

Surveillance
Psittacosis is a reportable condition in most states.

 

Wednesday, January 12, 2011

UK: GPs Warned Over Bacterial Co-Infections With Flu

 

 


# 5225

 

 

 

During the winter - when influenza rates rise - so often do the rates of serious bacterial infections, such as meningococcal disease and co-infections by Streptococcus pyogenes (Group A Streptococcus), Streptococcus pneumoniae, Staphylococcus aureus and Haemophilus influenzae.

 

These complications may beset otherwise healthy flu patients, who are not normally considered at greater risk of severe illness from the virus. 

 

In recent days, the British press has carried a number of stories of patients severely ill, or even succumbing, to some of these complications.

 

Meningococcal disease often appears first as a flu-like illness, which can make it very difficult to differentiate it from a garden variety influenza-like-illness (ILI). 

 

Accordingly, a letter from Dame Sally Davies, the Department of Health’s interim chief medical officer, has reminded GPs to be cognizant of ‘an increase in a number of significant bacterial infections that may occur as co-infections with flu.

 

A notice appears on the Pulse Today website, with a brief description of the letter’s contents.

 

 

GPs warned over bacterial co-infection in flu

12 Jan 11

By Lilian Anekwe

GPs are being warned of soaring rates of bacterial infections occurring in people with flu this season.

 

(Continue . . . )

 

Friday, January 22, 2010

Flu’s Double Whammy

 

 

 

# 4277

 

 

From the American Journal of Pathology today we get this study which uses a mouse model to explore the mechanisms that lead to an increased pathogenesis and mortality when bacterial pneumonia is immediately preceded by influenza.

 

The lead researcher describes what he suggests is a`lethal synergy between influenza virus and the bacterial respiratory pathogen, H. influenzae’. 

 

Their research indicates that influenza and bacterial pneumonia infections that - on their own would normally be non-lethal - grow in pathogenicity when the bacterial pneumonia directly follows an influenza infection.

 

Just over three weeks ago we saw this report, which correlates the higher pandemic mortality rates experienced in Argentina with bacterial pneumonias.

 

Study: Streptococcus Pneumoniae In Fatal H1N1 Cases In Argentina

 

And from 2008, we get these two studies from the CDC’s EID Journal.

 

EID Journal: Bacterial Pneumonia and Pandemic Planning
Study: Deaths From Bacterial Pneumonia During 1918-1919 Influenza Pandemic


One of our best defenses against these types of secondary infections are the child and adult pneumonia vaccines.  

 

CDC Promoting Better Uptake Of PPSV in Adults
PCV7 Pneumococcal Vaccine Would Save Lives In A Pandemic


 

Here is the press release on this latest study, followed by a link to the study’s abstract.

 

 

Contact: Angela Colmone, Ph.D.
acolmone@asip.org
301-634-7953
American Journal of Pathology

Double trouble: Bacterial super-infection after the flu

San Diego, CA – Current research suggests that the flu may predispose to secondary bacterial infections, which account for a significant proportion of mortality during flu pandemics. The related report by Lee et al, "A mouse model of lethal synergism between influenza virus and Haemophilus influenzae," appears in the February 2010 issue of The American Journal of Pathology.

 

Influenza affects between three and five million people annually, causing up to 500,000 deaths worldwide. While most people will recover in one to two weeks, others will develop life-threatening conditions such as pneumonia or bronchitis. High-risk groups for seasonal influenza include the very young and old, people with compromised immune systems, and pregnant women. However, during influenza pandemics, mortality may be significant in previously healthy young adults.

 

A common complication of flu infection is a secondary "super-infection" by bacteria, which greatly increases the morbidity and mortality of the disease. The most common bacterial agents found following flu pandemics have been Streptococcus pneumoniae, Haemophilus influenzae, Group A Streptococcus, and Staphylococcus aureus. Furthermore, reports of infection with antibiotic-resistant strains have been increasing in recent years.

 

To explore the mechanisms governing the increased pathogenesis of flu upon super-infection, a group led by Dr. Sally R. Sarawar of the Torrey Pines Institute for Molecular Studies, San Diego, California confirmed that otherwise nonlethal influenza and H. influenzae infections cause high mortality rates in mice when flu infection precedes H. influenzae infection. Their data confirm a restricted time period for this heightened susceptibility and highlight that excessive bacterial, and not viral, growth is associated with increased lethality. The fact that this increased mortality was observed in both immunocompromised and immunocompetent mice suggests that even normal healthy people are at increased risk for complications following bacterial super-infection.

 

Lee et al suggest that the "lethal synergy between influenza virus and the bacterial respiratory pathogen, H. influenzae, is mediated by innate immunity. They observed that severe damage to the airways was an early event in the co-infected mice, eventually leading to death. This underscores the need for early antiviral and antibiotic treatment to combat severe disease in human patients and highlights the importance of vaccination and effective hygiene measures to prevent secondary bacterial infections during influenza infection. This new model will be useful for further investigating the mechanisms underlying severe disease caused by the interaction between influenza virus and bacteria, which may have resulted in numerous deaths during influenza pandemics and continues to constitute a significant clinical problem in susceptible individuals." Currently ongoing studies suggest that this model may also be useful for identifying target molecules for the development of novel therapeutic agents and strategies.

 

Lee LN, Dias P, Han D, Yoon S, Shea A, Zakharov V, Parham D, Sarawar SR. A Mouse Model of Lethal Synergism Between Influenza Virus and Haemophilus influenzae. American Journal Of Pathology, 2009; DOI: 10.2353/ajpath.2010.090596